Subsequent survival analysis revealed a poorer prognosis in SAMHD1-positive DLBCL patients (Figure 1D), indicating that high SAMHD1 expression led to inferior prognosis in DLBCL patients. This evidence concerns the gene SAMHD1 and diffuse large B-cell lymphoma.